Publication:
Fluorescein angiography as a primary guide for reduced-fluence photodynamic therapy for the treatment of chronic central serous chorioretinopathy.

dc.contributor.authorKoytak, A
dc.contributor.authorBayraktar, H
dc.contributor.authorOzdemir, H
dc.contributor.institutionauthorKOYTAK, İBRAHİM ARİF
dc.contributor.institutionauthorÖZDEMİR, MEHMET HAKAN
dc.date.accessioned2020-04-20T20:59:07Z
dc.date.available2020-04-20T20:59:07Z
dc.date.issued2020-04-09T00:00:00Z
dc.identifier.citationKoytak A., Bayraktar H., Ozdemir H., -Fluorescein angiography as a primary guide for reduced-fluence photodynamic therapy for the treatment of chronic central serous chorioretinopathy.-, International ophthalmology, 2020
dc.identifier.doi10.1007/s10792-020-01350-3
dc.identifier.pubmed32274613
dc.identifier.scopus85083046298
dc.identifier.urihttps://hdl.handle.net/20.500.12645/16437
dc.language.isoen
dc.titleFluorescein angiography as a primary guide for reduced-fluence photodynamic therapy for the treatment of chronic central serous chorioretinopathy.
dc.typeArticle
dspace.entity.typePublication
local.avesis.id5659b6b0-7973-45d4-884a-7d48f2196ca8
local.publication.isinternational1
relation.isAuthorOfPublicationad20e4da-e310-4188-9b32-8fb51734eb5f
relation.isAuthorOfPublication9060b30f-7577-47e2-8bee-b2e001a19e7f
relation.isAuthorOfPublication.latestForDiscoveryad20e4da-e310-4188-9b32-8fb51734eb5f
Files